Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848430 | SCV002104658 | uncertain significance | Hereditary spastic paraplegia | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038701 | SCV004864673 | uncertain significance | not specified | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.893A>G (p.Y298C) alteration is located in exon 11 (coding exon 11) of the ERLIN1 gene. This alteration results from a A to G substitution at nucleotide position 893, causing the tyrosine (Y) at amino acid position 298 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |